Skip to Content

L194 (Ropinirole Hydrochloride Extended-Release 8 mg)

Pill with imprint L194 is Red, Capsule-shape and has been identified as Ropinirole Hydrochloride Extended-Release 8 mg. It is supplied by Trigen Laboratories, Inc..

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L194

Ropinirole Hydrochloride Extended-Release

Imprint:
L194
Strength:
8 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Trigen Laboratories, Inc.
National Drug Code (NDC):
13811-0642

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide